Design and synthesis of artificial phospholipid for selective cleavage of integral membrane protein

Chemical Communications

Volumn , Issue 36, 2005, Pages 4575-4577

  Furuta, Takumi ^a   Sakai, Minatsu ^a   Hayashi, Hiroyasu ^a   Asakawa, Tomohiro ^a   Kataoka, Fumi ^a   Fujii, Satoshi ^a   Suzuki, Takashi ^a   Suzuki, Yasuo ^a   Tanaka, Kiyoshi ^a   Fishkin, Nathan ^b   Nakanishi, Koji ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; IRON CHELATING AGENT; MEMBRANE PROTEIN; PHOSPHOLIPID; VIRUS PROTEIN;

ALKYLATION; ARTICLE; DRUG DESIGN; DRUG MECHANISM; DRUG SYNTHESIS; HYDROGENATION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REDUCTION;

EID: 26444552839     PISSN: 13597345     EISSN: None     Source Type: Journal    
DOI: 10.1039/b507917a     Document Type: Article

References (26)

1. S. A. Datwyler and C. F. Meares, Trends Biochem. Sci., 2000, 25, 408;
2. A. Schepartz and B. Cuenoud, J. Am. Chem. Soc., 1990, 112, 3247;
3. D. Hoyer, H. Cho and P. G. Schultz, J. Am. Chem. Soc., 1990, 112, 3249;
4. M. R. Ermacora, D. W. Ledman and R. O. Fox, Nat. Struct. Biol., 1996, 3, 59.
5. J. Gallagher, O. Zelenko, A. D. Walts and D. S. Sigman, Biochemistry, 1998, 37, 2096.
6. J. Suh, Acc. Chem. Res., 2003, 36, 562.
7. Only intramolecular cleavage reactions of integral membrane proteins, using Fe(III)-EDTA and Cu-phenanthroline complexes conjugated to cysteine thiols, have been reported. See, J. Wu, D. M. Perrin, D. S. Sigman and H. R. Kaback, Proc. Natl. Acad. Sci. USA, 1995, 92, 9186;
8. A. Gelasco, R. K. Crouch and D. R. Knapp, Biochemistry, 2000, 39, 4907;
9. J. B. Ghaim, D. P. Greiner, C. F. Meares and R. B. Gennis, Biochemistry, 1995, 34, 11311.
10. B. C. Roy, B. Chandra, D. Hromas and S. Mallik, Org. Lett., 2003, 5, 11.
11. E. Drakopoulou, G. M. Tsivgoulis, A. Mukhopadhyay and A. Brisson, Tetrahedron Lett., 2000, 41, 4131.
12. R. W. Storrs, F. D. Tropper, H. Y. Li, C. K. Song, J. K. Kuniyoshi, D. A. Sipkins, K. C. P. Li and M. D. Bednarski, J. Am. Chem. Soc., 1995, 117, 7301.
13. Artificial phospholipids possessing a photoactivatable group and a disulfide moiety have been prepared for the investigation of protein-lipid and lipid-lipid interactions, respectively. For example, see, G. D. Prestwich, Acc. Chem. Res., 1996, 29, 503;
14. Y. Ogawa, W. Hahn, P. Garnier, N. Higashi, D. Massotte, M.-H. Metz-Boutigue, B. Rousseau, M. Kodaka, J. Sunamoto, G. Ourisson and Y. Nakatani, Chem. Eur. J., 2002, 8, 1843;
15. M. Sugahara, M. Uragami and S. E. Regen, J. Am. Chem. Soc., 2003, 125, 13040.
16. For example, see, M. Beck, F. Siebert and T. P. Sakmar, FEBS Lett., 1998, 436, 304.
17. Phosphoroamidite 5 was prepared according to the reported procedure. See, K. Fukase, T. Yoshimura, S. Kotani and S. Kusumoto, Bull. Chem. Soc. Jpn., 1994, 67, 473.
18. The observation of a phosphorus resonance at -5.65 ppm suggested the oxidation occurred selectively at the phosphorus atom.
19. Because of the abundance (ca. 20% of total viral proteins) and ease of detection by SDS-PAGE gel electrophoresis without any troublesome purification, HA has been selected as a protein substrate for this experiment. For the X-ray structure of HA, see, I. A. Wilson, J. J. Skehel and D. C. Wiley, Nature, 1981, 289, 366.
20. L. M. Selimova, V. M. Zaides and V. M. Zhdanov, J. Virol., 1982, 44, 450.
21. 2. Both these mechanisms of amide bond cleavage have been reported. See, T. M. Rana and C. F. Meares, Proc. Natl. Acad. Sci. USA, 1991, 88, 10578;
22. I. E. Platis, M. R. Ermacora and R. O. Fox, Biochemistry, 1993, 32, 12761.
23. For example, see, D. P. Greiner, K. A. Hughes, A. H. Gunasekera and C. F. Meares, Proc. Natl. Acad. Sci. USA, 1996, 93, 71.
24. E. D. Green, G. Adelt, J. U. Baenziger, S. Wilson and H. Van Halbeek, J. Biol. Chem., 1988, 263, 18253.
25. It might be assumed that both the sugar side chains modifying the extramembrane domain of HA and the viral membrane protect HA from the cleavage reaction by inhibition of the approach of Fe(III)-EDTA complex.
26. For example, see, N. Kunishima, Y. Shimada, Y. Tsuji, T. Sato, M. Yamamoto, T. Kumasaka, S. Nakanishi, H. Jingami and K. Morikawa, Nature, 2000, 407, 971.